Pharmaceutical

Is HIV-TB coinfection treatment entering a new frontier?

TB is the leading determiner of death in patients with HIV, yet while new drug research is underway, funding and accessible treatments remain distant.

Mar 20, 2024 - 00:00
Is HIV-TB coinfection treatment entering a new frontier?
TB is the leading determiner of death in patients with HIV, yet while new drug research is underway, funding and accessible treatments remain distant.
Read the original article

Tags:

Previous Article

Pushing the limit of the periodic table with superheavy elements

Next Article

Prevention over cure? Understanding the evolved care continuum and centralised data

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The biggest health care deals of 2023

STAT+: The biggest health care deals of 2023

Dec 17, 2023

Opinion: Doctors — and patients — must seek alternatives to long-term steroids

Opinion: Doctors — and patients — must seek alternative...

Oct 16, 2023

Biosyngen’s liver cancer therapy receives fast track designation

Biosyngen’s liver cancer therapy receives fast track de...

Feb 2, 2024